US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Belite Bio, Inc | $156.00 | -0.1% | $4.96B | -132.2 | -25.2% | — | Healthcare | 154.4% | — | ||
| 2 | Tarsus Pharmaceuticals, Inc. | $63.96 | -1.2% | $2.72B | -40.2 | 58.2% | — | Healthcare | 35.1% | 129% | ||
| 3 | Kodiak Sciences Inc. | $43.68 | -4.8% | $2.31B | -13.0 | -12.9% | — | Healthcare | 1028.7% | — | ||
| 4 | Ocular Therapeutix, Inc. | $9.68 | -0.3% | $2.12B | -6.8 | -27% | — | Healthcare | 37.3% | -12.8% | ||
| 5 | Oculis Holding AG | $31.09 | 5.1% | $1.8B | -11.4 | -23.7% | — | Healthcare | 68.8% | — | ||
| 6 | Viridian Therapeutics, Inc. | $16.97 | -3.2% | $1.44B | -5.1 | 9.6% | — | Healthcare | 38.1% | 23382.8% | ||
| 7 | EyePoint Pharmaceuticals, Inc. | $13.41 | 0.4% | $1.12B | -4.2 | -36.8% | — | Healthcare | 120.2% | -27.5% | ||
| 8 | Opus Genetics, Inc. | $5.36 | 1.9% | $346M | -2.5 | -56.4% | — | Healthcare | 425.5% | 74.6% | ||
| 9 | LENZ Therapeutics, Inc. | $9.72 | 0.4% | $278M | -3.4 | 41.1% | — | Healthcare | -61.6% | — | ||
| 10 | Aldeyra Therapeutics, Inc. | $1.73 | -0.6% | $104M | -1.8 | 2.7% | — | Healthcare | -13.9% | — | ||
| 11 | OKYO Pharma Limited | $1.62 | -3.6% | $66M | -13.5 | 0.1% | — | Healthcare | 10.2% | — | ||
| 12 | Skye Bioscience, Inc. | $0.90 | 5.6% | $32M | -0.6 | -94.4% | — | Healthcare | -50.6% | — | ||
| 13 | Outlook Therapeutics, Inc. | $0.22 | -6.9% | $14M | -0.1 | 62.5% | — | Healthcare | -84.7% | 20.8% | ||
| 14 | NovaBay Pharmaceuticals, Inc. | $1.88 | -3.6% | $11M | -0.7 | 101.1% | — | Healthcare | -35.2% | -74.7% | ||
| 15 | Kiora Pharmaceuticals, Inc. | $2.45 | -2.4% | $8M | 2.8 | -234.6% | — | Healthcare | -26.9% | -100% | ||
| 16 | Clearside Biomedical, Inc. | $0.41 | 0% | $2M | -0.1 | 23.9% | — | Healthcare | -96.8% | -56.8% | ||
| 17 | KALA BIO, Inc. | $0.08 | -27.8% | $617676 | -0.0 | 52.4% | — | Healthcare | -97.6% | 262.9% |
Showing 17 stocks